{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:43:43Z","timestamp":1786121023031,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["2025-1.2.4-T\u00c9T-2025-00007"],"award-info":[{"award-number":["2025-1.2.4-T\u00c9T-2025-00007"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0208"],"award-info":[{"award-number":["P1-0208"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Voltage-gated sodium channel Na\n                    <jats:sub>V<\/jats:sub>\n                    1.7 is a key mediator of electrical excitability and signal transmission in peripheral nociceptors and has emerged as a highly attractive therapeutic target for the development of novel analgesic agents. However, the development of selective Na\n                    <jats:sub>V<\/jats:sub>\n                    1.7 inhibitors has been characterized by significant challenges, with repeated failures in clinical trials despite encouraging preclinical data. In this study, we developed and validated a series of ligand-based pharmacophore models (LBPMs) that can be useful for the discovery of novel Na\n                    <jats:sub>V<\/jats:sub>\n                    1.7 inhibitors with improved selectivity profiles. Using the VGSC database as our primary data source, we focused on sulfonamide-based inhibitors targeting the voltage-sensing domain IV (VSD-IV). Validation against active compounds and decoys demonstrated that most models achieved good discrimination performance with high areas under the curve (AUC) and strong enrichment factors. External validation using 22 inhibitors extracted from recent literature confirmed the models\u2019 capability to identify novel Na\n                    <jats:sub>V<\/jats:sub>\n                    1.7 inhibitors. Virtual screening of 3\u00a0million commercially available compounds retrieved promising hits and known inhibitors, with molecular docking studies revealing binding modes consistent with established sulfonamide-based inhibitors. Experimental validation identified one compound with measurable selectivity for Na\n                    <jats:sub>V<\/jats:sub>\n                    1.7 over Na\n                    <jats:sub>V<\/jats:sub>\n                    1.5, providing preliminary support for the utility of the developed virtual screening workflow. In parallel, we developed Na\n                    <jats:sub>V<\/jats:sub>\n                    1.5 LBPMs to assess selectivity profiles and minimize potential cardiotoxic effects. Overall, our findings provide valuable computational tools and structural insights for the rational design of selective Na\n                    <jats:sub>V<\/jats:sub>\n                    1.7 inhibitors, offering important starting points for developing analgesics with reduced off-target effects.\n                  <\/jats:p>","DOI":"10.1007\/s10822-026-00898-z","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:38:27Z","timestamp":1786070307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ligand-based pharmacophore modeling for the discovery of NaV1.7 inhibitors"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8549-3386","authenticated-orcid":false,"given":"Martina","family":"Piga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lukacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Pesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"V\u00e1rady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nace","family":"Zidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5534-209X","authenticated-orcid":false,"given":"Tihomir","family":"Toma\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"898_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-pharmtox-010818-021757","volume":"60","author":"WA Catterall","year":"2020","unstructured":"Catterall WA, Lenaeus MJ, Gamal El-Din TM (2020) Structure and pharmacology of voltage-gated sodium and calcium channels. Annu Rev Pharmacol Toxicol 60:133\u2013154. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021757","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"898_CR2","doi-asserted-by":"publisher","first-page":"908867","DOI":"10.3389\/fphar.2022.908867","volume":"13","author":"D Jiang","year":"2022","unstructured":"Jiang D, Zhang J, Xia Z (2022) Structural advances in voltage-gated sodium channels. Front Pharmacol 13:908867. https:\/\/doi.org\/10.3389\/fphar.2022.908867","journal-title":"Front Pharmacol"},{"key":"898_CR3","doi-asserted-by":"publisher","first-page":"2281714","DOI":"10.1080\/19336950.2023.2281714","volume":"17","author":"WA Catterall","year":"2023","unstructured":"Catterall WA (2023) Voltage gated sodium and calcium channels: discovery, structure, function, and Pharmacology. Channels 17:2281714. https:\/\/doi.org\/10.1080\/19336950.2023.2281714","journal-title":"Channels"},{"key":"898_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-024-01108-x","volume":"24","author":"M Alsaloum","year":"2025","unstructured":"Alsaloum M, Dib-Hajj SD, Page DA et al (2025) Voltage-gated sodium channels in excitable cells as drug targets. Nat Rev Drug Discov 24:358\u2013378. https:\/\/doi.org\/10.1038\/s41573-024-01108-x","journal-title":"Nat Rev Drug Discov"},{"key":"898_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/19336950.2015.1079674","volume":"9","author":"SK Bagal","year":"2015","unstructured":"Bagal SK, Marron BE, Owen RM et al (2015) Voltage gated sodium channels as drug discovery targets. Channels 9:360\u2013366. https:\/\/doi.org\/10.1080\/19336950.2015.1079674","journal-title":"Channels"},{"key":"898_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41583-020-00418-4","volume":"22","author":"MH Meisler","year":"2021","unstructured":"Meisler MH, Hill SF, Yu W (2021) Sodium channelopathies in neurodevelopmental disorders. Nat Rev Neurosci 22:152\u2013166. https:\/\/doi.org\/10.1038\/s41583-020-00418-4","journal-title":"Nat Rev Neurosci"},{"key":"898_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40364-024-00620-x","volume":"12","author":"H Liu","year":"2024","unstructured":"Liu H, Weng J, Huang CL-H, Jackson AP (2024) Voltage-gated sodium channels in cancers. Biomark Res 12:70. https:\/\/doi.org\/10.1186\/s40364-024-00620-x","journal-title":"Biomark Res"},{"key":"898_CR8","doi-asserted-by":"publisher","first-page":"e202400162","DOI":"10.1002\/cphc.202400162","volume":"25","author":"VF Palmisano","year":"2024","unstructured":"Palmisano VF, Anguita-Ortiz N, Faraji S, Nogueira JJ (2024) Voltage\u2010gated ion channels: structure, pharmacology and photopharmacology. ChemPhysChem 25:e202400162. https:\/\/doi.org\/10.1002\/cphc.202400162","journal-title":"ChemPhysChem"},{"key":"898_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0002-9343(97)00358-6","volume":"104","author":"SC Hebert","year":"1998","unstructured":"Hebert SC (1998) General principles of the structure of ion channels. Am J Med 104:87\u201398. https:\/\/doi.org\/10.1016\/S0002-9343(97)00358-6","journal-title":"Am J Med"},{"key":"898_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.nurt.2007.01.013","volume":"4","author":"D Conte Camerino","year":"2007","unstructured":"Conte Camerino D, Tricarico D, Desaphy J-F (2007) Ion channel pharmacology. Neurotherapeutics 4:184\u2013198. https:\/\/doi.org\/10.1016\/j.nurt.2007.01.013","journal-title":"Neurotherapeutics"},{"key":"898_CR11","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.drudis.2019.05.014","volume":"24","author":"L Xu","year":"2019","unstructured":"Xu L, Ding X, Wang T et al (2019) Voltage-gated sodium channels: structures, functions, and molecular modeling. Drug Discov Today 24:1389\u20131397. https:\/\/doi.org\/10.1016\/j.drudis.2019.05.014","journal-title":"Drug Discov Today"},{"key":"898_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/jm3011433","volume":"56","author":"SK Bagal","year":"2013","unstructured":"Bagal SK, Brown AD, Cox PJ et al (2013) Ion channels as therapeutic targets: a drug discovery perspective. J Med Chem 56:593\u2013624. https:\/\/doi.org\/10.1021\/jm3011433","journal-title":"J Med Chem"},{"key":"898_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1220844110","author":"K McCormack","year":"2013","unstructured":"McCormack K, Santos S, Chapman ML et al (2013) Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.1220844110","journal-title":"Proc Natl Acad Sci"},{"key":"898_CR14","doi-asserted-by":"publisher","first-page":"aac5464","DOI":"10.1126\/science.aac5464","volume":"350","author":"S Ahuja","year":"2015","unstructured":"Ahuja S, Mukund S, Deng L et al (2015) Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist. Science 350:aac5464. https:\/\/doi.org\/10.1126\/science.aac5464","journal-title":"Science"},{"key":"898_CR15","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1039\/C7MD00131B","volume":"8","author":"DC Pryde","year":"2017","unstructured":"Pryde DC, Swain NA, Stupple PA et al (2017) The discovery of a potent Nav 1.3 inhibitor with good oral pharmacokinetics. MedChemComm 8:1255\u20131267. https:\/\/doi.org\/10.1039\/C7MD00131B","journal-title":"MedChemComm"},{"key":"898_CR16","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1021\/acs.jmedchem.8b01906","volume":"62","author":"JV Mulcahy","year":"2019","unstructured":"Mulcahy JV, Pajouhesh H, Beckley JT et al (2019) Challenges and opportunities for therapeutics targeting the voltage-gated sodium channel isoform NaV 1.7. J Med Chem 62:8695\u20138710. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01906","journal-title":"J Med Chem"},{"key":"898_CR17","doi-asserted-by":"publisher","first-page":"115530","DOI":"10.1016\/j.ejmech.2023.115530","volume":"258","author":"N Zidar","year":"2023","unstructured":"Zidar N, Toma\u0161i\u010d T, Kikelj D et al (2023) New aryl and acylsulfonamides as state-dependent inhibitors of Nav1.3 voltage-gated sodium channel. Eur J Med Chem 258:115530. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115530","journal-title":"Eur J Med Chem"},{"key":"898_CR18","doi-asserted-by":"publisher","first-page":"e84151","DOI":"10.7554\/eLife.84151","volume":"12","author":"M Kschonsak","year":"2023","unstructured":"Kschonsak M, Jao CC, Arthur CP et al (2023) Cryo-EM reveals an unprecedented binding site for NaV1.7 inhibitors enabling rational design of potent hybrid inhibitors. eLife 12:e84151. https:\/\/doi.org\/10.7554\/eLife.84151","journal-title":"eLife"},{"key":"898_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1124\/molpharm.123.000789","volume":"105","author":"JM Gilchrist","year":"2024","unstructured":"Gilchrist JM, Yang N-D, Jiang V, Moyer BD (2024) Pharmacologic characterization of LTGO-33, a selective small molecule inhibitor of the voltage-gated sodium channel NaV1.8 with a unique mechanism of action. Mol Pharmacol 105:233\u2013249. https:\/\/doi.org\/10.1124\/molpharm.123.000789","journal-title":"Mol Pharmacol"},{"key":"898_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s40265-025-02178-w","volume":"85","author":"SJ Keam","year":"2025","unstructured":"Keam SJ (2025) Suzetrigine: first approval. Drugs 85:845\u2013851. https:\/\/doi.org\/10.1007\/s40265-025-02178-w","journal-title":"Drugs"},{"key":"898_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11916-026-01472-w","volume":"30","author":"A Abd-Elsayed","year":"2026","unstructured":"Abd-Elsayed A, Hashimoto N, Reilly M et al (2026) Selective NaV1.8 inhibition for pain management: current evidence and future potential of suzetrigine. Curr Pain Headache Rep 30:35. https:\/\/doi.org\/10.1007\/s11916-026-01472-w","journal-title":"Curr Pain Headache Rep"},{"key":"898_CR22","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41467-022-28808-5","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Xu F, Xu H et al (2022) Structural basis for modulation of human NaV1.3 by clinical drug and selective antagonist. Nat Commun 13:1286. https:\/\/doi.org\/10.1038\/s41467-022-28808-5","journal-title":"Nat Commun"},{"key":"898_CR23","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1038\/s41467-023-38942-3","volume":"14","author":"Q Wu","year":"2023","unstructured":"Wu Q, Huang J, Fan X et al (2023) Structural mapping of Nav1.7 antagonists. Nat Commun 14:3224. https:\/\/doi.org\/10.1038\/s41467-023-38942-3","journal-title":"Nat Commun"},{"key":"898_CR24","doi-asserted-by":"publisher","DOI":"10.2147\/JRLCR.S46843","author":"A Voet","year":"2014","unstructured":"Voet A, Qing X, Lee XY et al (2014) Pharmacophore modeling: advances, limitations, and current utility in drug discovery. J Recept Ligand Channel Res. https:\/\/doi.org\/10.2147\/JRLCR.S46843","journal-title":"J Recept Ligand Channel Res"},{"key":"898_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1517\/14728222.2016.1162295","volume":"20","author":"EC Emery","year":"2016","unstructured":"Emery EC, Luiz AP, Wood JN (2016) Nav 1.7 and other voltage-gated sodium channels as drug targets for pain relief. Expert Opin Ther Targets 20:975\u2013983. https:\/\/doi.org\/10.1517\/14728222.2016.1162295","journal-title":"Expert Opin Ther Targets"},{"key":"898_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/164_2018_97","volume-title":"Voltage-gated Sodium Channels: Structure, Function and Channelopathies","author":"J Payandeh","year":"2018","unstructured":"Payandeh J, Hackos DH (2018) Selective ligands and drug discovery targeting the voltage-gated sodium channel Nav1.7. In: Chahine M (ed) Voltage-gated sodium channels: structure, function and channelopathies. Springer International Publishing, Cham, pp 271\u2013306"},{"key":"898_CR27","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.2147\/JPR.S207610","volume":"12","author":"RSY Ma","year":"2019","unstructured":"Ma RSY, Kayani K, Oshodi DW et al (2019) Voltage gated sodium channels as therapeutic targets for chronic pain. J Pain Res Volume 12:2709\u20132722. https:\/\/doi.org\/10.2147\/JPR.S207610","journal-title":"J Pain Res Volume"},{"key":"898_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1039\/D2MD00081D","volume":"13","author":"Y Kitano","year":"2022","unstructured":"Kitano Y, Shinozuka T (2022) Inhibition of NaV 1.7: the possibility of ideal analgesics. RSC Med Chem 13:895\u2013920. https:\/\/doi.org\/10.1039\/D2MD00081D","journal-title":"RSC Med Chem"},{"key":"898_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13321-022-00655-y","volume":"14","author":"G Wang","year":"2022","unstructured":"Wang G, Yu J, Du H et al (2022) VGSC-DB: an online database of voltage-gated sodium channels. J Cheminformatics 14:75. https:\/\/doi.org\/10.1186\/s13321-022-00655-y","journal-title":"J Cheminformatics"},{"key":"898_CR30","unstructured":"LigandScout v.4.3 Available from Inte:Ligand. https:\/\/www.inteligand.com\/ligandscout"},{"key":"898_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"G Wolber","year":"2005","unstructured":"Wolber G, Langer T (2005) LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 45:160\u2013169. https:\/\/doi.org\/10.1021\/ci049885e","journal-title":"J Chem Inf Model"},{"key":"898_CR32","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/acs.jcim.7b00505","volume":"57","author":"N-O Friedrich","year":"2017","unstructured":"Friedrich N-O, de Bruyn Kops C, Flachsenberg F et al (2017) Benchmarking commercial conformer ensemble generators. J Chem Inf Model 57:2719\u20132728. https:\/\/doi.org\/10.1021\/acs.jcim.7b00505","journal-title":"J Chem Inf Model"},{"key":"898_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fchem.2018.00229","volume":"6","author":"G Poli","year":"2018","unstructured":"Poli G, Seidel T, Langer T (2018) Conformational sampling of small molecules With iCon: performance assessment in comparison with OMEGA. Front Chem 6:229. https:\/\/doi.org\/10.3389\/fchem.2018.00229","journal-title":"Front Chem"},{"key":"898_CR34","first-page":"43","volume":"3","author":"C Sieb","year":"2007","unstructured":"Sieb C, Meinl T, Berthold MR (2007) parallel and distributed data pipelining with KNIME. Mediterr J Comput Netw 3:43\u201351","journal-title":"Mediterr J Comput Netw"},{"key":"898_CR35","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1038\/s41598-018-26444-y","volume":"8","author":"P Lukacs","year":"2018","unstructured":"Lukacs P, F\u00f6ldi MC, Val\u00e1nszki L et al (2018) Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog. Sci Rep 8:8110. https:\/\/doi.org\/10.1038\/s41598-018-26444-y","journal-title":"Sci Rep"},{"key":"898_CR36","doi-asserted-by":"publisher","first-page":"738460","DOI":"10.3389\/fphar.2021.738460","volume":"12","author":"K Pesti","year":"2021","unstructured":"Pesti K, F\u00f6ldi MC, Zboray K et al (2021) Characterization of compound-specific, concentration-independent biophysical properties of sodium channel inhibitor mechanism of action using automated patch-clamp electrophysiology. Front Pharmacol 12:738460. https:\/\/doi.org\/10.3389\/fphar.2021.738460","journal-title":"Front Pharmacol"},{"key":"898_CR37","doi-asserted-by":"publisher","first-page":"738260","DOI":"10.3389\/fphar.2021.738260","volume":"12","author":"P Lukacs","year":"2021","unstructured":"Lukacs P, Pesti K, F\u00f6ldi MC et al (2021) An advanced automated patch clamp protocol design to investigate drug\u2014ion channel binding dynamics. Front Pharmacol 12:738260. https:\/\/doi.org\/10.3389\/fphar.2021.738260","journal-title":"Front Pharmacol"},{"key":"898_CR38","doi-asserted-by":"publisher","first-page":"809802","DOI":"10.3389\/fphar.2022.809802","volume":"13","author":"B Hackl","year":"2022","unstructured":"Hackl B, Lukacs P, Ebner J et al (2022) The bradycardic agent ivabradine acts as an atypical inhibitor of voltage-gated sodium channels. Front Pharmacol 13:809802. https:\/\/doi.org\/10.3389\/fphar.2022.809802","journal-title":"Front Pharmacol"},{"key":"898_CR39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.sbi.2017.02.002","volume":"43","author":"V Carnevale","year":"2017","unstructured":"Carnevale V, Klein ML (2017) Small molecule modulation of voltage gated sodium channels. Curr Opin Struct Biol 43:156\u2013162. https:\/\/doi.org\/10.1016\/j.sbi.2017.02.002","journal-title":"Curr Opin Struct Biol"},{"key":"898_CR40","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55:6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"key":"898_CR41","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/ph14080789","volume":"14","author":"T Toma\u0161i\u010d","year":"2021","unstructured":"Toma\u0161i\u010d T, Zubrien\u0117 A, Skok \u017d et al (2021) Selective DNA gyrase inhibitors: multi-target in silico profiling with 3D-pharmacophores. Pharmaceuticals 14:789. https:\/\/doi.org\/10.3390\/ph14080789","journal-title":"Pharmaceuticals"},{"key":"898_CR42","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1021\/jm501981g","volume":"58","author":"M De Lera Ruiz","year":"2015","unstructured":"De Lera Ruiz M, Kraus RL (2015) Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications. J Med Chem 58:7093\u20137118. https:\/\/doi.org\/10.1021\/jm501981g","journal-title":"J Med Chem"},{"key":"898_CR43","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1016\/j.bmcl.2014.06.038","volume":"24","author":"SK Bagal","year":"2014","unstructured":"Bagal SK, Chapman ML, Marron BE et al (2014) Recent progress in sodium channel modulators for pain. Bioorg Med Chem Lett 24:3690\u20133699. https:\/\/doi.org\/10.1016\/j.bmcl.2014.06.038","journal-title":"Bioorg Med Chem Lett"},{"key":"898_CR44","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.1021\/acs.jmedchem.6b00425","volume":"59","author":"EF DiMauro","year":"2016","unstructured":"DiMauro EF, Altmann S, Berry LM et al (2016) Application of a parallel synthetic strategy in the discovery of biaryl acyl sulfonamides as efficient and selective NaV1.7 inhibitors. J Med Chem 59:7818\u20137839. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00425","journal-title":"J Med Chem"},{"key":"898_CR45","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1016\/j.bmcl.2018.08.007","volume":"28","author":"SJ McKerrall","year":"2018","unstructured":"McKerrall SJ, Sutherlin DP (2018) Nav1.7 inhibitors for the treatment of chronic pain. Bioorg Med Chem Lett 28:3141\u20133149. https:\/\/doi.org\/10.1016\/j.bmcl.2018.08.007","journal-title":"Bioorg Med Chem Lett"},{"key":"898_CR46","doi-asserted-by":"publisher","first-page":"e72468","DOI":"10.7554\/eLife.72468","volume":"11","author":"J Johnson","year":"2022","unstructured":"Johnson J, Focken T, Khakh K et al (2022) NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats. eLife 11:e72468. https:\/\/doi.org\/10.7554\/eLife.72468","journal-title":"eLife"},{"key":"898_CR47","doi-asserted-by":"publisher","first-page":"128892","DOI":"10.1016\/j.bmcl.2022.128892","volume":"73","author":"JR Butler","year":"2022","unstructured":"Butler JR, Rescourio G, Milgram BC et al (2022) Discovery of pyridyl urea sulfonamide inhibitors of NaV1.7. Bioorg Med Chem Lett 73:128892. https:\/\/doi.org\/10.1016\/j.bmcl.2022.128892","journal-title":"Bioorg Med Chem Lett"},{"key":"898_CR48","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1021\/acschemneuro.3c00757","volume":"15","author":"SJ Goodchild","year":"2024","unstructured":"Goodchild SJ, Shuart NG, Williams AD et al (2024) Molecular pharmacology of selective NaV 1.6 and Dual NaV 1.6\/NaV 1.2 channel inhibitors that suppress excitatory neuronal activity Ex Vivo. ACS Chem Neurosci 15:1169\u20131184. https:\/\/doi.org\/10.1021\/acschemneuro.3c00757","journal-title":"ACS Chem Neurosci"},{"key":"898_CR49","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.124.002273","author":"M Su","year":"2024","unstructured":"Su M, Ou-yang X, Zhou P et al (2024) Inhibition of TTX-S Na+ currents by a novel blocker QLS-278 for antinociception. J Pharmacol Exp Ther. https:\/\/doi.org\/10.1124\/jpet.124.002273","journal-title":"J Pharmacol Exp Ther"},{"key":"898_CR50","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1021\/acsmedchemlett.3c00079","volume":"14","author":"N Karanjule","year":"2023","unstructured":"Karanjule N, Hayashi N, Suzuki S et al (2023) N -Aryl indoles as a novel class of potent NaV 1.7 inhibitors. ACS Med Chem Lett 14:788\u2013793. https:\/\/doi.org\/10.1021\/acsmedchemlett.3c00079","journal-title":"ACS Med Chem Lett"},{"key":"898_CR51","unstructured":"Markworth CJ, Marron BE, Rawson DJ et al (2012) Chemical compounds PCT Int. Appl. WO2012004706"},{"key":"898_CR52","unstructured":"Gonzales JE, Termin III, Martinborough AP (2005) Esther, chemical compounds PCT Int. Appl. WO2005013914"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00898-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:38:30Z","timestamp":1786070310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00898-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["898"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00898-z","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"198"}}